13
Considerations to integrate vaccine trials to the plague response: perspectives from Madagascar Workshop « Efficacy trials of Plague Vaccines: endpoints, trial design and site selection » Pr André SPIEGEL Directeur de l’Institut Pasteur de Madagascar April 23, 2018 INSERM, 101 rue de Tolbiac, Paris

Considerations to integrate vaccine trials to the plague ... · Elements of outbreak situation on vaccine trial •Point 2 •Recruitment and follow-up •Acceptability of concerned

  • Upload
    others

  • View
    3

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Considerations to integrate vaccine trials to the plague ... · Elements of outbreak situation on vaccine trial •Point 2 •Recruitment and follow-up •Acceptability of concerned

Considerations to integrate vaccine trials to the plague response: perspectives from Madagascar

Workshop « Efficacy trials of Plague Vaccines: endpoints, trial design and site selection »

Pr André SPIEGEL

Directeur de l’Institut Pasteur de Madagascar

April 23, 2018

INSERM, 101 rue de Tolbiac, Paris

Page 2: Considerations to integrate vaccine trials to the plague ... · Elements of outbreak situation on vaccine trial •Point 2 •Recruitment and follow-up •Acceptability of concerned

Plague in Madagascar 1898 : introduction of the Plague in Madagascar (Toamasina)

• 1898 : Toamasina epidemic

• 24 november 1898 : 1th cas

• 1921 : Antananarivo • Following the construction railways

• Spread in Madagascar

• Endemic to the present day

2

Page 3: Considerations to integrate vaccine trials to the plague ... · Elements of outbreak situation on vaccine trial •Point 2 •Recruitment and follow-up •Acceptability of concerned

Plague in Madagascar Endemic area with a plague season

• Endemic area • Rural areas of the Central highlands

• Natural foci of plague

• Altitude > 800 m

• Plague Season

• October – April

• Bubonic form predominant • 2015 : 326 cases 32 % of pneumonic forms

• 2016: 283 cases 12% of pneumonic forms

3

Bubonic Plague Pneumonic plague

Plague in Madagascar 1998-2016 Geographical distribution (n=13,234)

Source: Plague Unité – LCP, IPM

Page 4: Considerations to integrate vaccine trials to the plague ... · Elements of outbreak situation on vaccine trial •Point 2 •Recruitment and follow-up •Acceptability of concerned

Ankazobe

Analamahitsy

Moramanga

Toamasina

Antetezambary

AntohomadinikaAnkoronaAndramasina

Ambodisakoa

Ampanefena

27/08/2017au

28/08/2017

Légende

Déplacement

03/09/2017au???

03/09/2017

au06/09/2017

Plague epidemic in 2017 The beginning

• Index case : end of August

• 31 year-old-man

• Died from respiratory distress on August 28

• Going from endemic area and travelling in a bush taxi

• Ankazobe Antananarivo Moramanga

• September 2, 3

• 2 passengers died (Toamasina, Antananarivo)

• Two deceased in the same family around second passenger

• September 11 : confirmation PP outbreak

• 47 year old woman died in Antananarivo

• Linked to Tamatave cluster 4

Source: IPM

Page 5: Considerations to integrate vaccine trials to the plague ... · Elements of outbreak situation on vaccine trial •Point 2 •Recruitment and follow-up •Acceptability of concerned

Plague epidemic in 2017 Keys information

5

050

100150200250300350400450500550

31-07 07-08 14-08 21-08 28-08 04-09 11-09 18-09 25-09 02-10 09-10 16-10 23-10 30-10 06-11 13-11 20-11

Nb

of

no

tifi

ed

cas

es

Weeks

Epidemic plague in Madagascar Suspect

Probable

Confirmed

August 28 November 27

2414 cases

1902 Pneumonic (78,8%)

22.7% confirmed or probable

322 Bubonic (15,4%)

34.1% confirmed or probable

7318 contacts of plague cases • Identification, treatment, follow-up

• Chemoprophylaxis national regimen : triméthoprime-sulfaméthoxazole

Page 6: Considerations to integrate vaccine trials to the plague ... · Elements of outbreak situation on vaccine trial •Point 2 •Recruitment and follow-up •Acceptability of concerned

Plague epidemic in 2017 Keys information

• Response coordinated by MoH co-led by WHO

• Enhanced epidemiologic surveillance

• Laboratory confirmation • RDT, PCR-qPCR, culture, no serology

• Contact

• identification, antibiotic administration and follow-up

• Case Management (isolation and treatment)

• Safe and dignified burials

• Social mobilization and community engagement

6

Page 7: Considerations to integrate vaccine trials to the plague ... · Elements of outbreak situation on vaccine trial •Point 2 •Recruitment and follow-up •Acceptability of concerned

Elements of outbreak situation on vaccine trial Different stages of a vaccine trial

• Objective: evaluate effectiveness of plague vaccine

• Key points for vaccine trial protocol

• Public health authorities agreement

• National ethic committee authorization

• Recruitment and follow-up of volunteers

• Vaccinated and non vaccinated

• Explanation, consent

• Vaccination

• Diagnosis of plague cases to evaluate the vaccine

7

Page 8: Considerations to integrate vaccine trials to the plague ... · Elements of outbreak situation on vaccine trial •Point 2 •Recruitment and follow-up •Acceptability of concerned

Elements of outbreak situation on vaccine trial

• Point 1

• Public health authorities agreement

• National ethic committee authorization

• During epidemic

• Authorities little concerned by research activity

• Priority given to controlling the epidemic

• Difficulties to introduce news policies during epidemic

• Therapeutic treatment regimen

• Secure burial protocol

• Contact and convince authorities from the beginning of outbreak

8

Page 9: Considerations to integrate vaccine trials to the plague ... · Elements of outbreak situation on vaccine trial •Point 2 •Recruitment and follow-up •Acceptability of concerned

Elements of outbreak situation on vaccine trial

• Point 2

• Recruitment and follow-up

• Who will implement the trial ?

• Health care workers with a heavy workload

• Health care system saturated

• Medical care complicated because health service saturated

• Means insufficient because not adapted to an epidemic situation

•Need to strengthen care teams • Teams in charge of the trial are familiar with the field conditions and

Malagasy culture +++

9

Page 10: Considerations to integrate vaccine trials to the plague ... · Elements of outbreak situation on vaccine trial •Point 2 •Recruitment and follow-up •Acceptability of concerned

Elements of outbreak situation on vaccine trial

• Point 2

• Recruitment and follow-up

• Acceptability of concerned population

• Suspicion of population +++

• Violent reactions to rumors of vaccinations against the plague

• People don’t want to be used as an experiment during an epidemic

• Duration of trial

• Risk that end of the epidemic happens before the end of the trial

• Need for clear timeline

• Authorization, recruitment, vaccination schedule, follow-up…

10

Page 11: Considerations to integrate vaccine trials to the plague ... · Elements of outbreak situation on vaccine trial •Point 2 •Recruitment and follow-up •Acceptability of concerned

Elements of outbreak situation on vaccine trial

• Points 3

• Diagnosis of plague cases to evaluate the vaccine

• Find the plague cases +++

• 2017 plague outbreak

• Clinical management of patients in 9 to dedicated care centers

• Population : very important fear of plague

• Reluctance to consult health care system

• hide the disease ++

• Don’t want to be hospitalized => reputation of HCS

• Still shameful disease

impact on evaluation of the vaccine

• Very high antibio-prophylactic use in non contact subjects

Possible impact on clinical forms, diagnostic test results

11

Page 12: Considerations to integrate vaccine trials to the plague ... · Elements of outbreak situation on vaccine trial •Point 2 •Recruitment and follow-up •Acceptability of concerned

Elements of outbreak situation on vaccine trial

• Point 3

• Diagnosis of plague cases to evaluate the vaccine

• How to define a plague case?

• Plague Biologic diagnosis during epidemic is essential

• IPM : only laboratory

• More than 100 samples / days (RDT, PCR or qPCR, culture)

• Serology not possible

• impossible to routinely collect samples of blood

• not planned in the national strategy

• Sensitivity and specificity <100%

• Differential diagnosis: most often not done in HCS

• Clinical suspicion suspect case even if tests are negative

• Need for a sensitive and specific biological diagnosis

12

Page 13: Considerations to integrate vaccine trials to the plague ... · Elements of outbreak situation on vaccine trial •Point 2 •Recruitment and follow-up •Acceptability of concerned

Conclusion Elements of outbreak situation on vaccine trial

• incidence

• favors the demonstration of the efficacy of a vaccine (especially by increasing the power of study)

• But some epidemic-related conditions can make it complicated

• Priority for the authorities

• Acceptability of the population

• Implementation difficult given the heavy workload of health workers.

• Uncontrolled consumption of antibiotics

• Sensitivity and specificity of diagnostic tests

• Race against time ! 13

interpretation of results difficult